[go: up one dir, main page]

CN1323210A - 治疗精神分裂症的方法及应用该方法的装置 - Google Patents

治疗精神分裂症的方法及应用该方法的装置 Download PDF

Info

Publication number
CN1323210A
CN1323210A CN99812210A CN99812210A CN1323210A CN 1323210 A CN1323210 A CN 1323210A CN 99812210 A CN99812210 A CN 99812210A CN 99812210 A CN99812210 A CN 99812210A CN 1323210 A CN1323210 A CN 1323210A
Authority
CN
China
Prior art keywords
nicotine
officinal salt
treatment device
medical treatment
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99812210A
Other languages
English (en)
Chinese (zh)
Inventor
R·麦考尼
V·西姆德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of CN1323210A publication Critical patent/CN1323210A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN99812210A 1998-10-16 1999-10-02 治疗精神分裂症的方法及应用该方法的装置 Pending CN1323210A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19847715A DE19847715A1 (de) 1998-10-16 1998-10-16 Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
DE19847715.5 1998-10-16

Publications (1)

Publication Number Publication Date
CN1323210A true CN1323210A (zh) 2001-11-21

Family

ID=7884666

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99812210A Pending CN1323210A (zh) 1998-10-16 1999-10-02 治疗精神分裂症的方法及应用该方法的装置

Country Status (10)

Country Link
EP (1) EP1121126A1 (es)
JP (1) JP2002527478A (es)
KR (1) KR20010080135A (es)
CN (1) CN1323210A (es)
AR (1) AR020815A1 (es)
AU (1) AU6199299A (es)
BR (1) BR9914570A (es)
CA (1) CA2341855A1 (es)
DE (1) DE19847715A1 (es)
WO (1) WO2000023077A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1907273B (zh) * 2005-08-01 2011-12-28 日东电工株式会社 烟碱透皮制剂的制备方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110953A1 (de) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten
US7455654B2 (en) * 2003-10-28 2008-11-25 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
EP2706854A4 (en) * 2011-05-09 2014-12-03 Envivo Pharmaceuticals Inc TREATMENT OF COGNITIVE DISORDERS BY CERTAIN AGONISTS OF THE ALPHA-7 NICOTINIC RECEPTOR IN COMBINATION WITH NICOTINE
CZ309812B6 (cs) * 2021-05-25 2023-11-01 Consumer Brands International s.r.o Směs pro výrobu nikotinových sáčků a způsob její výroby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
GB9614902D0 (en) * 1996-07-16 1996-09-04 Rhodes John Sustained release composition
US5776956A (en) * 1996-07-30 1998-07-07 Lectec Corporation Use of cotinine in treating psychiatric disorders
US5776957A (en) * 1996-11-15 1998-07-07 The University Of Kentucky Research Foundation Nornicotine enantiomers for use as a treatment for dopamine related conditions and disease states

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1907273B (zh) * 2005-08-01 2011-12-28 日东电工株式会社 烟碱透皮制剂的制备方法

Also Published As

Publication number Publication date
BR9914570A (pt) 2001-07-03
CA2341855A1 (en) 2000-04-27
AR020815A1 (es) 2002-05-29
AU6199299A (en) 2000-05-08
JP2002527478A (ja) 2002-08-27
DE19847715A1 (de) 2000-04-20
WO2000023077A1 (de) 2000-04-27
KR20010080135A (ko) 2001-08-22
EP1121126A1 (de) 2001-08-08

Similar Documents

Publication Publication Date Title
Grond et al. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl
Lehmann et al. Transdermal fentanyl: clinical pharmacology
US20070191815A1 (en) Biosynchronous transdermal drug delivery
JP2009544619A5 (es)
NO20110342L (no) Fentanylpreparat for nasal administrering
TW200904407A (en) Oronasopharyngeally deliverable pharmaceutical composition for the prevention/alleviation and/or treatment of restless limb disorder
CA2762107A1 (en) Sublingual dexmedetomidine compositions and methods of use thereof
CZ20014187A3 (cs) Farmaceutický preparát s účinnou látkou diamorfin a jeho pouľití při způsobu oąetřování závislosti na opiátech
JPH07503232A (ja) メラトニンの制御経皮投与
JP2013516482A (ja) 局所経皮用デクスメデトミジン組成物およびそれらの使用方法
HUE026994T2 (en) Liquid nasal spray containing low dose naltrexone
AU2010282660B2 (en) Methods for iontophoretically treating nausea and migraine
CN1323210A (zh) 治疗精神分裂症的方法及应用该方法的装置
CZ289395A3 (en) Transdermic therapeutic system for administration of serotonin agonists
US20150352038A1 (en) A dosage form for administering an active principle for accelerated sleep induction and/or for treating sleep disorders and/or for treating a central nervous system disorder
JP2005525329A5 (es)
Stanley Anesthesia for the 21st century
JP2003176227A (ja) 製薬組成物、喫煙を控えている患者の喫煙禁断症状を軽減する方法及び患者の喫煙禁断症状を軽減するキット
Stanley et al. Novel delivery systems: oral transmucosal and intranasal transmucosal
MX2007009968A (es) Metodo para una politerapia medicamentosa y combinaciones de medicamentos apropiadas para la misma.
WO2018071656A1 (en) Formulations for treatment of migraines
CN1067875C (zh) 雌二醇周效透皮吸收贴片
CN1226163A (zh) 治疗和/或预防痴呆的制剂
WO2021011597A1 (en) Pharmaceutical formulations containing gaboxadol for therapeutic treatment
CA2547873A1 (en) Tetrapeptide regulating blood glucose level in diabetes mellitus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication